Ofloxacin for Typhoid Fever
For fully fluoroquinolone-susceptible typhoid fever, ofloxacin 300 mg orally twice daily for 7 days is effective in adults, but azithromycin or ceftriaxone should be used instead if nalidixic acid resistance is present (MIC ≥0.25 µg/mL), as treatment failure rates exceed 40% with ofloxacin in this setting 1, 2.
Dosing Regimens by Clinical Context
Adults with Susceptible Strains
- Standard dose: 300 mg orally twice daily for 7 days 3
- Alternative: 400 mg twice daily for 7 days has been studied but offers no clear advantage 4
- Short course: 15 mg/kg/day for 2-3 days may be effective for fully susceptible strains, though 7-day courses have lower failure rates 5, 6
The FDA label does not specifically list typhoid fever as an approved indication, but the WHO guidelines explicitly recommend ofloxacin as first-line treatment for fully susceptible Salmonella typhi 1.
Children
- Dose: 15 mg/kg/day divided twice daily for 7 days (maximum 300 mg per dose) 5
- Safety: Multiple studies in children, including those as young as infants, showed no cartilage toxicity or other significant adverse effects 5, 7
The WHO 2012 guidelines list ofloxacin among first-line fluoroquinolones for pediatric typhoid 1.
Critical Resistance Considerations
The single most important factor determining ofloxacin effectiveness is fluoroquinolone susceptibility 2:
- MIC ≤0.125 µg/mL: 96% treatment success
- MIC 0.25-0.50 µg/mL: 73% treatment success
- MIC 1.0 µg/mL: 53% treatment success
If nalidixic acid resistance is present, do not use ofloxacin 6, 7, 2. In one study, 3 of 5 patients (60%) with nalidixic acid-resistant strains failed ofloxacin treatment compared to only 4% with sensitive strains 6. Switch to azithromycin (preferred) or ceftriaxone 1, 7.
Renal Impairment Adjustments
Per FDA labeling 4:
- CrCl 20-50 mL/min: Give usual dose (300 mg) once every 24 hours instead of twice daily
- CrCl <20 mL/min: Give 150 mg (half the usual dose) once every 24 hours
The half-life increases linearly with declining renal function, requiring these adjustments to prevent accumulation 8.
Pregnancy
Ofloxacin is contraindicated in pregnancy due to fluoroquinolone class concerns about fetal cartilage development. Use azithromycin or ceftriaxone instead 1, 9.
Fluoroquinolone Allergy
Use azithromycin 1 g on day 1, then 500 mg daily for days 2-6 1, 7, 9. This regimen showed superior outcomes to ofloxacin in multidrug-resistant/nalidixic acid-resistant typhoid, with 82% cure rate versus 64% for ofloxacin 7.
Alternative: Ceftriaxone 2-4 g IV daily (or 100 mg/kg/day in children) for 7-14 days 1.
Comparative Effectiveness
Recent evidence shows azithromycin outperforms ofloxacin when resistance is present 1, 7:
- Shorter fever clearance time: 5.8 days with azithromycin vs 8.2 days with ofloxacin
- Lower fecal carriage: 1.6% with azithromycin vs 19.4% with ofloxacin
- Better cure rates: 82% vs 64% in resistant strains
The 2024 WHO guidelines note that azithromycin had lower clinical failure rates (OR 0.48) and shorter hospital stays than fluoroquinolones 1.
Common Pitfalls
Using ofloxacin without susceptibility testing: Always check for nalidixic acid resistance or obtain MIC values. Empiric use in areas with high fluoroquinolone resistance leads to treatment failure.
Inadequate duration: While 2-3 day courses work for fully susceptible strains, 7-day courses have lower relapse rates. Don't shorten treatment in resistant infections.
Ignoring drug interactions: Separate ofloxacin from antacids, iron, zinc, or calcium supplements by at least 2 hours 4.
Using in children without justification: Though safe in studies, fluoroquinolones remain second-line in children when alternatives exist 1.
Continuing despite slow response: If fever persists beyond 5 days, suspect resistance and switch to azithromycin or ceftriaxone rather than extending ofloxacin 7, 2.